[CITATION][C] Pathophysiology and therapy of pemphigus in the 21st century
JR Stanley - The Journal of Dermatology, 2001 - Wiley Online Library
JR Stanley
The Journal of Dermatology, 2001•Wiley Online Library2) Wu H, Wang ZH, Yan A, et al: Protection of neonates against pemphigus foliaceus by
desmoglein 3, N Engl J Med, 343: 31–35, 2000. 3) Stanley JR: Therapy of pemphigus
vulgaris, Arch Dermatol, 135: 76–78, 1999. 4) Aberer W, Wolff Schreiner EC, Stingl G, Wolff
K: Azathioprine in the treatment of pemphigus vulgaris, A long-term follow-up, J Am Acad
Dermatol, 161: 527–533, 1987.
desmoglein 3, N Engl J Med, 343: 31–35, 2000. 3) Stanley JR: Therapy of pemphigus
vulgaris, Arch Dermatol, 135: 76–78, 1999. 4) Aberer W, Wolff Schreiner EC, Stingl G, Wolff
K: Azathioprine in the treatment of pemphigus vulgaris, A long-term follow-up, J Am Acad
Dermatol, 161: 527–533, 1987.
2) Wu H, Wang ZH, Yan A, et al: Protection of neonates against pemphigus foliaceus by desmoglein 3, N Engl J Med, 343: 31–35, 2000. 3) Stanley JR: Therapy of pemphigus vulgaris, Arch Dermatol, 135: 76–78, 1999. 4) Aberer W, Wolff Schreiner EC, Stingl G, Wolff K: Azathioprine in the treatment of pemphigus vulgaris, A long-term follow-up, J Am Acad Dermatol, 161: 527–533, 1987.
Wiley Online Library